160 related articles for article (PubMed ID: 27663978)
1. CXCL13 rather than IL-31 is a potential indicator in patients with hepatocellular carcinoma.
Li B; Su H; Cao J; Zhang L
Cytokine; 2017 Jan; 89():91-97. PubMed ID: 27663978
[TBL] [Abstract][Full Text] [Related]
2. Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.
Duan Z; Gao J; Zhang L; Liang H; Huang X; Xu Q; Zhang Y; Shen T; Lu F
Oncotarget; 2015 Dec; 6(42):44239-53. PubMed ID: 26517519
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
[TBL] [Abstract][Full Text] [Related]
4. The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling.
Li C; Kang D; Sun X; Liu Y; Wang J; Gao P
Biomed Res Int; 2015; 2015():345413. PubMed ID: 26161394
[TBL] [Abstract][Full Text] [Related]
5. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
6. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
7. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
8. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
9. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
10. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma.
Iliaz R; Akyuz U; Tekin D; Serilmez M; Evirgen S; Cavus B; Soydinc H; Duranyildiz D; Karaca C; Demir K; Besisik F; Kaymakoglu S; Akyuz F
Arab J Gastroenterol; 2016 Dec; 17(4):164-167. PubMed ID: 27916547
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Wang F; Ying H; He B; Pan Y; Sun H; Wang S
Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
[TBL] [Abstract][Full Text] [Related]
12. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
13. Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma.
Çavuş B; Akyuz F; İliaz R; Akyuz U; Duranyıldız D; Serilmez M; Tekin D; Evirgen S; Karaca Ç; Demir K; Beşışık F; Kaymakoğlu S
Exp Oncol; 2020 Sep; 42(3):208-214. PubMed ID: 32996733
[TBL] [Abstract][Full Text] [Related]
14. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy.
Cha H; Lee EJ; Seong J
World J Gastroenterol; 2017 Mar; 23(11):2077-2085. PubMed ID: 28373775
[TBL] [Abstract][Full Text] [Related]
15. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
16. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
17. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinoma.
Yang XP; Zhou LX; Yang QJ; Liu L; Cai Y; Ma SL
Cancer Biomark; 2016 Sep; 17(3):271-279. PubMed ID: 27802203
[TBL] [Abstract][Full Text] [Related]
19. Serum CD166: a novel hepatocellular carcinoma tumor marker.
Ma L; Lin J; Qiao Y; Weng W; Liu W; Wang J; Sun F
Clin Chim Acta; 2015 Feb; 441():156-62. PubMed ID: 25562819
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma.
Yao H; Liu X; Chen S; Xia W; Chen X
Int J Clin Exp Pathol; 2015; 8(11):14830-5. PubMed ID: 26823812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
